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Chromatin-modifying enzymes have long been proposed to be the authors of an epigenetic
language, but the origin and meaning of the messages they write in chromatin are still mysterious.
Recent studies suggesting that the effects of diet can be passed on epigenetically to offspring add
weight to the idea that histones act as metabolic sensors, converting changes in metabolism into
stable patterns of gene expression. The challenge will now be to understand how localized fluctu-
ations in levels of metabolites control chromatin modifiers in space and time, translating a dynamic
metabolic state into a histone map.The excitement about epigenetics and
chromatin remodeling that has charac-
terized biological research during the
past two decades is in large part
focused on a single question: how is
gene expression stably reprogrammed
in response to transient external stimuli?
Plasticity is at the heart of all biological
functions, and, in the case of epigenetic
control, it involves a large variety of
mechanisms that have evolved to en-
sure adaptability to a multitude of sig-
nals, conditions, and organisms (Turner,
2009).
Epigenetic mechanisms control chro-
matin structure through DNAmethylation,
RNA interference, histone variants, and
posttranslational modifications. The inter-
play of these regulatory mechanisms
suggests that the coordinate and pro-
gressive combination of these processes
may ‘‘lock’’ the epigenome in specific
states, thereby determining the fate
and physiology of a given cell (Borrelli
et al., 2008). The molecular machines
implicated in interpreting changes in
the environment and translating them
into ad hoc modulations of the epige-
nome are constructed from various inter-
acting components, including kinases,
acetyltransferases, and methyltrans-
ferases (Lee and Workman, 2007). These
enzymes use cellular metabolites as sour-
ces of phosphate, acetyl, or methyl
groups, respectively. Considering the
myriad of residues on either DNA or24 Cell 148, January 20, 2012 ª2012 Elsevierhistone tails that can potentially undergo
modifications at a given time in the
genome, appropriate levels of phosphate,
acetyl, and methyl groups need to be
available to the enzymes eliciting the
modifications. This raises an interesting
possibility: do changes in the levels of
cellular metabolites influence the epige-
nome? Also, to what extent do those
alterations induce inheritable effects?
Here we review some recent ideas
and discoveries that illustrate how the
link between metabolism and epige-
netics extends to previously unappreci-
ated levels.
Metabolic States Influence
Chromatin Structure
Because histone-modifying enzymes
consume key metabolites, it is conceiv-
able that they interpret the metabolic
state of a given cell by changing chro-
matin modification patterns (Figure 1).
Consistent with this, a global reduction
of nuclear acetyl-CoA levels decreases
histone acetylation, whereas reduced
levels of NAD+ have the opposite effect,
inhibiting histone deacetylation (Nakahata
et al., 2009; Wellen et al., 2009). However,
the global level of a given metabolite
is unlikely to be the sole determinant of
the enzymatic activity of a specific chro-
matin remodeler. Indeed, rising levels
of ATP do not increase the phosphoryla-
tion of all substrates equally, clearly indi-
cating that changes in metabolite levelsInc.alone are not the only impetus for
epigenetic editing. Histone-modifying en-
zymes can be recruited to specific chro-
mosomal domains via their interaction
with DNA-binding factors, and this
can stimulate enzymatic activity locally.
Alternatively, the inhomogeneous distri-
bution of metabolites within a cell could
lead to a local depletion or an excess
of cofactors for histone-modifying en-
zymes with a similar outcome. Such
spatial concentration differences could
be achieved by the subcellular localiza-
tion of enzymes responsible for the
synthesis of individual metabolites, and
hence the distribution would be different
for each metabolite.
Similarly, enzymes that use the same
metabolite but modify different sub-
strates, such as DNA or histone methyl-
transferases, may compete with each
other leading to either one or the other
methylation product. This raises the
question of whether the affinities of
enzymes for their cofactors differ from
each other such that they would be
able to gauge metabolite concentration.
Unfortunately information on the kinetic
parameters of histone-modifying en-
zymes is sparse, and studies of the
dynamic changes in metabolite concen-
trations are limited. Despite this paucity
of available data, it is clear that modifying
enzymes vary significantly in their affini-
ties for their cofactors and have KM values
that are similar to the corresponding
Figure 1. Chromatin-Remodeling Enzymes ‘‘Sense’’ Cellular Metabolism
Schematic representation of the histone H3 tail with residues that can bemodified by various enzymes (E),
leading to phosphorylation (P), acetylation (Ac), methylation (Me), ubiquitination (Ub), and glycosylation
(Gly). These modifications have been associated with changes in chromatin organization, gene activation,
silencing, and several other nuclear functions. Each enzyme utilizes cellularmetabolites, whose availability
would dictate the efficacy of the enzymatic reaction.cofactor concentrations in vivo (Albaugh
et al., 2011; Sauve et al., 2006). Global
and local fluctuations of cofactor concen-
trations would therefore have an effect
on the ability of these enzymes to fulfill
their function. Such changes in concen-
trations may be caused by circadian
rhythmicity, nutritional inputs, variation
in carbon sources, or changes in oxygen-
ation of the cell. Most of these external
influences will globally change the
cofactor concentration within the cell
and will therefore have a global impact
on histone modifications. However, as
mentioned above, accumulating evidence
indicates that histone-modifying enzymes
could also make use of local changes
in metabolite concentration to elicit
domain-specific chromatin remodeling
(Katoh et al., 2011; Wellen et al., 2009).
Subcellular Distribution of
Metabolites: Chromatin ‘‘Niches’’
or Microdomains?
The cytosol and, even more strikingly, the
nucleus of a eukaryotic cell contain a very
high concentration of biological macro-
molecules such as proteins and DNA
(200 mg/ml). This dense and very viscous
medium severely restricts free diffusion
of small molecules, thereby significantly
slowing down biochemical reactions that
are purely diffusion controlled. Intrigu-
ingly, several metabolic pathways are
conveniently organized in multiprotein
complexes to allow reaction channeling,which facilitates signaling. A classical
example in this respect is fatty acid syn-
thase (FAS), a large multiprotein complex
that has been proposed to be constructed
in a ‘‘molecular assembly line’’ to promote
efficient channeling of substrates from
one enzyme to the next (Leibundgut
et al., 2008). Recent data suggest that
close coupling of histone-modifying
enzymeswith enzymescritical for cofactor
synthesis also exists in the nucleus
(Katoh et al., 2011; Wellen et al., 2009).
For example, Mat IIIa, an enzyme that
catalyzes the formation of SAM from
methionine and ATP, interacts with
a sequence-specific transcription factor
in order tomaintainahighSAMconcentra-
tion, which is ultimately used by an H3K9-
specific histone methyltransferase to
repress transcription (Katoh et al., 2011).
Similarly, depending on the main carbon
source, ATP-citrate lyase (glucose) or the
acetyl-CoA synthetase ACS1 (acetate)
localize to thenuclei of LN229cells (Wellen
et al., 2009) or S. cerevisiae (Takahashi
et al., 2006) to provide a sufficient source
of acetyl groups for histone acetyltrans-
ferases. Within those nuclear metabolic
domains, eraser enzymes such as deace-
tylases might generate a local increase in
acetate groups, which could be used by
ACS1 to generate acetyl-CoA for the cor-
responding HAT enzyme. It is plausible
that such a dynamic turnover of acetyl
groups could be critical for transcriptional
activation. The presence of ‘‘niches’’ orCell 14microdomains of chromatin modifica-
tions, where the substrates for histone
modifiers are immediately replenished
after the modification, could also help to
insulate specific domains against spikes
of metabolic changes (Figure 2). Impor-
tantly, the degree of insulation would not
be homogenous along the chromatin.
Indeed, it could very much depend on
the level of molecular crowding, making
constitutive heterochromatin much less
sensitive to metabolic alterations than
euchromatic regions (Bancaud et al.,
2009).
Posttranslational Regulation
of Histone Modifiers
Histones are not the only proteins that are
modified by acetyltransferases, methyl-
transferases, or kinases. Fluctuations in
cofactor concentrations could therefore
lead to alterations not only in histone
modifications but also in posttranslational
modifications of the enzymes that then in
turn modify histones. Indeed, many of
these enzymes or accessory proteins are
modified, with the modification affecting
their enzymatic activity (Vaquero et al.,
2007), their ability to bind chromatin (Wei
et al., 2011), or the subunit composition
of a large complex (Huang et al., 2007).
Such modification networks result in
complex feedback loops that translate
physiological changes into changes
within the epigenome. High glucose levels
can, for example, stimulate the activity of
the mammalian methyltransferase MLL5
through increased GlcNAcylation (Fujiki
et al., 2009). Thismodification is catalyzed
by the interacting O-GlcNac transferase
(OGT), which is dependent on the pres-
ence of sufficient nuclear UDP-GlcNac.
UDP-GlcNac is synthesized from extra-
cellular glucose by the hexosamine
biosynthesis pathway, thereby linking
the activity of a histone-modifying enzyme
directly to the extracellular concentration
of glucose. This connection between
glucose levels and chromatin structure
seems to be evolutionarily conserved, as
a mutation of the OGT gene in Drosophila
leads to a polycomb-like phenotype (Sin-
clair et al., 2009).
The systematic analysis of reversible
lysine acetylation (Kim et al., 2006;
Choudhary et al., 2009) has revealed
a role for acetylation in directly regulating
energy metabolism as most of the8, January 20, 2012 ª2012 Elsevier Inc. 25
Figure 2. Hypothetical Organization of Chromatin ‘‘Niches’’ or
Microdomains
The concentration of metabolites and their biosynthetic enzymes may vary
within subdomains of chromatin, leading to localized transcriptional activation
or inactivation. In this example, in a microdomain with high levels of acetyl-
CoA, there will be higher availability of acetyl groups, facilitating acetylation of
histone and nonhistone proteins in transcriptional complexes (TC), leading to
activation of gene expression. On the other hand, high levels of NAD+ within
a ‘‘niche’’ would lead to the activation of HDACs of the sirtuin class, inducing
deacetylation of substrates and transcriptional silencing. Such local differ-
ences could be achieved by local ‘‘trapping’’ of enzymes responsible for
critical metabolic pathways within the domain.acetylated proteins in mito-
chondria are involved in
various catabolic pathways.
However, acetylation is not
limited to the mitochondria
as a large fraction of acety-
lated proteins are either
exclusively nuclear or shuttle
between cytoplasm and the
nucleus (Choudhary et al.,
2009). Interestingly, many
components within large
protein assemblies that either
bind or modify chromatin are
heavily acetylated. Despite
this wealth of information on
lysine acetylation, only in
very few cases have the func-
tion or the regulation of the
modification been explored.
For example, HATs are acety-
lated on lysine residues, an
event that increases their
activity by protecting them
from degradation (as in thecase of p300), modulating their nuclear
transport (as for P/CAF), or increasing
the binding affinity for acetyl-CoA (as for
Rtt109). In contrast to most acetyltrans-
ferases, the methyltransferase SUV39H1
is inhibited by reversible lysine acetylation
of a single lysine within the catalytic SET
domain (Vaquero et al., 2007). In light of
the known importance of acetyl-CoA
levels on HAT activity, it is very likely that
all of these modifications are in fact
coupled to metabolism and could trans-
late physiological states into alterations
of gene expression.
NAD+, a Master Metabolite?
A large variety of enzymes depend on the
coenzyme NAD+, including at least two
groups of chromatin regulators, the class
III HDACs (sirtuins) and the PARPs (poly-
ADP ribose polymerases). Changing
levels of a single metabolite may therefore
impact independent groups of enzymes
with different functions. Other enzymes
such as HATs may also be indirectly
affected by changing concentrations of
NAD+. Mutual interplays are also conceiv-
able within the sirtuin family. There are
seven sirtuins, which display distinct
distributions in the cytoplasm, nucleus,
and mitochondria. All seven sirtuins are
thought to require NAD+, although it is still
unclear whether their affinities for the26 Cell 148, January 20, 2012 ª2012 Elseviercoenzyme differ (Sauve et al., 2006). In
any case, it could be envisaged that the
relative activity of the three sirtuins
present in the nucleus (SIRT1, SIRT6,
and SIRT7) may modulate the local
concentration of NAD+, thereby resulting
in reciprocal regulation of the other sir-
tuins that may be localized in the same
or nearby chromatin microdomains. In
this respect, it is essential to evaluate
how the concentration of specific metab-
olites may vary in various physiological
conditions.
It has been shown that levels of NAD+
are regulated in a circadian manner,
establishing a direct link between cyclic
rhythms and energy metabolism in the
cell (Nakahata et al., 2009; Ramsey
et al., 2009). Although expression levels
of SIRT1 are noncyclic, HDAC activity is
known to fluctuate in a circadian manner
(Nakahata et al., 2008). Subsequent
studies revealed that the cyclic availability
of its own coenzyme, NAD+, is respon-
sible for these oscillations in SIRT1
HDAC activity (Nakahata et al., 2009;
Ramsey et al., 2009). NAD+ synthesis is
directly regulated by the circadian clock
machinery, which controls transcription
of the Nampt gene. This gene encodes
an enzyme (nicotinamide phosphoribosyl-
transferase; NAMPT) that elicits the
rate-limiting step in the NAD+-salvageInc.pathway. Thus, changes in
NAMPT activity directly dic-
tate levels of intracellular
NAD+. These findings suggest
that several SIRT1 targets are
likely to display circadian
oscillations in their acetyla-
tion. This is indeed the case
for K9/K14 histone H3 sites
at circadian gene promoters,
as well as BMAL1, a nonhis-
tone target of SIRT1 that
operates as a transcriptional
coactivator of the circadian
regulator CLOCK (Nakahata
et al., 2009).
These findings suggest
that the circadian clock
and energy metabolism are
directly coupled. This cou-
pling is based on chromatin
remodeling at specific ge-
nomic sites. Although the
specificity of action of these
events is still unclear, it ishowever evident that the circadian clock
is directly implicated in controlling the
intracellular levels of critical metabolites,
locking together the transcriptional feed-
back loop of the clock with the enzymatic
feedback loop of the NAD+ -salvage
pathway. The extent to which the clock
controls intracellular levels of other
metabolites is not known, but the
possibility is intriguing as a significant
fraction of the genome is transcriptionally
controlled by the circadian machinery.
Disease and Epigenetics—Is
Metabolism the Link?
Many metabolites have been shown to
have a direct effect on gene expression
patterns through binding to nuclear
receptors that in turn affect the tran-
scription of the gene they bind to. Inter-
estingly, even transient changes in the
nutrition can have a long-lasting impact
on gene expression patterns. This
memory of former metabolic states may
also be involved in disease progression.
For example, patients suffering from
diabetes mellitus are more prone to
develop medical complications associ-
ated with hyperglycemia, even though
their blood glucose is maintained at
normal levels by standard therapies.
Similar memory effects are also observed
during embryonic development or cellular
differentiation, where genes ‘‘remember’’
their activity states with the help of the
epigenetic machinery.
Several observations imply that varia-
tion in dietary composition can lead
to increased disease susceptibility in
subsequent generations, suggesting the
transmission of a metabolically induced
epigenetic signal to the next generation.
For example, children whose mothers
experienced the 1944 winter famine in
the Netherlands late in their pregnancy
have a smaller birth size and a higher
risk of developing cardiovascular disease,
obesity, and type 2 diabetes (Painter
et al., 2005). Another study shows that
the nutritional state during the slow
growth phase in puberty has a funda-
mental effect on the mortality of the
following generation (Kaati et al., 2002).
The mechanisms that direct the inheri-
tance of such predispositions to disease
are unknown, but the fact that they are
induced by metabolic changes and
show a high level of variability under-
scores their epigenetic nature.
Heritable effects of metabolic distur-
bances have been mimicked by the
ablation of key epigenetic enzymes. For
example, the liver-specific ablation of
theSirt1 gene leads to impairedmetabolic
signaling and causes hepatic steatosis
and inflammation when the animals are
fed a high-fat diet (Purushotham et al.,
2009). Pharmacological activation of
SIRT1, on the other hand, leads to
improved insulin sensitivity under insulin-
resistant conditions (Sun et al., 2007).
These findings pave the way to the
development of therapeutic strategies
that would use SIRT1 activators as
potential lead molecules for the treatment
of type 2 diabetes. The central function
of HDACs in modulating metabolic
circuits is also evident in mice deficient
in SIRT6, a nuclear sirtuin that is activated
through its association with chromatin.
These animals develop lethal hypogly-
cemia and die soon after birth (Zhong
et al., 2010). Finally, histone demethyla-
tion is also critical for metabolic regula-
tion. Mice carrying an inactive allele
of the gene encoding the histone H3K9-
specific demethylase KDM3a become
obese in adulthood and have increased
levels of circulating lipids. This metabolic
alteration is very likely due to an
increase in the abundance of repressiveH3K9me modifications and a conse-
quent downregulation of genes involved
in fatty acid oxidation (Tateishi et al.,
2009).
Major metabolic changes are frequently
observed in cancers, in which cells switch
to an anaerobic metabolism even in
the presence of oxygen. This so-called
‘‘Warburg Effect’’ is accompanied by
major alterations in gene expression
profile whose causes are likely to be asso-
ciated with specific chromatin-remodel-
ing events. Recently, the genes encoding
isoforms of the enzyme isocitrate dehy-
drogenase (IDH1 and IDH2) have been
found to be mutated in a large variety of
tumors. In addition to a reduction of the
central metabolite 2-oxoglutarate, the
mutated alleles of the Idh1 and Idh2 genes
generate the oncometabolite 2-hydroxy-
glutarate, which acts as an inhibitor for
several epigenetic modifiers, including
demethylases containing the jumonji
domain and the TET family of 5-methylcy-
tosine hydroxylases (Xu et al., 2011).
Thus, a defect in genes encoding meta-
bolic enzymes could directly influence
the enzymatic function of epigenetic
regulators, leading to an increase in
histone and DNA methylation. Causal
connections between IDH mutations,
changes in epigenetic modifications, and
the altered patterns of gene expression
observed when cancer cells switch to
an anaerobic metabolism have not yet
been demonstrated. However, it is
tempting to speculate that the epigenetic
reprogramming induced by an aberrant
metabolite plays an important role in this
process.
In addition to using multiple and varied
cofactors, epigenetic modifiers also have
vastly different kinetics (Barth and Imhof,
2010). This raises the question of the
length and amplitude of the metabolic
stimulus required to switch between
metabolic states.
Aswe begin to connect the threads link-
ing epigenetic modifications and meta-
bolic pathways, an important challenge
will be to determine how plastic the epige-
nome is to nutritional challenges and
whether epigenetic changes triggered
by altered metabolic states can be
reversed. Despite the fact that we are
only beginning to understand this dynamic
relationship, accumulating data already
give the German saying ‘‘man ist wasCell 14man isst’’ (one is what one eats) a
completely new meaning.
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